title: [Clinical and therapeutic aspects of alcohol withdrawal syndrome].
abstract: In this review the authors describe the symptomatology, and the etiopathogenetic hypothesis of alcohol withdrawal syndrome. Many drugs are used in the treatment of alcohol withdrawal syndrome: carbamazepine, clonidine, chlormethiazole, phenytoin and other compounds; actually benzodiazepines are the most important drugs for symptomatic relief to prevent major withdrawal syndrome. Particularly attention is recommended to the period of suspension with the aim of reducing alcohol consumption and correcting alcohol-related psychosocial problems.
authors.affiliation: USL n. 7, Val di Nievole, Toscana, Pisa.
authors.forename: M
authors.initials: M
authors.lastname: Miniati
authors.forename: A
authors.initials: A
authors.lastname: Bani
authors.forename: M
authors.initials: M
authors.lastname: Mauri
mesh_terms: D000428:Alcohol Drinking; D001569:Benzodiazepines / Q000008:administration & dosage / Q000627:therapeutic use*; D000431:Ethanol / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008297:Male; D012720:Severity of Illness Index; D013375:Substance Withdrawal Syndrome / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology
chemical_list: D001569:Benzodiazepines; D000431:Ethanol
vernacular_title: Aspetti clinici e terapeutici della sindrome d'astinenza da alcol.